Convergence, sampling and total order estimator effects on parameter orthogonality in global sensitivity analysis. [PDF]
Saxton H +4 more
europepmc +1 more source
Global sensitivity analysis informed model reduction and selection applied to a Valsalva maneuver model. [PDF]
Randall EB +3 more
europepmc +1 more source
Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case–Control Study
ABSTRACT Introduction Intracerebral Hemorrhage (ICH) is a leading cause of morbidity and mortality worldwide and lacks effective therapeutic interventions. Despite previous studies, the genetic underpinnings of ICH remain poorly understood. We sought to investigate the role of copy number variants (CNVs) in ICH pathophysiology to identify novel ...
Savvina Prapiadou +12 more
wiley +1 more source
Improved efficacy behavioral modeling of microwave circuits through dimensionality reduction and fast global sensitivity analysis. [PDF]
Koziel S +2 more
europepmc +1 more source
Ranking non-pharmaceutical interventions against Covid-19 global pandemic using global sensitivity analysis-Effect on number of deaths. [PDF]
Hanthanan Arachchilage K, Hussaini MY.
europepmc +1 more source
Optimizing human activity patterns using global sensitivity analysis [PDF]
Geoffrey Fairchild +4 more
openalex +1 more source
Organic Growth Theory for Global Sustainable Competitiveness and COVID-19 Sensitivity Analysis
Ahmad Karnama
openalex +2 more sources
Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test
ABSTRACT Objective A 2‐min digital clock‐drawing test (DCTclock) captures more granular features of the clock‐drawing process than the pencil‐and‐paper clock‐drawing test, revealing more subtle deficits at the preclinical stage of Alzheimer's disease (AD). A previous cross‐sectional study demonstrated that worse DCTclock performance was associated with
Jessie Fanglu Fu +16 more
wiley +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source

